ORIGINAL ARTICLE

Prevalence and Awareness of Hypertension in Seven Distinct Geographic Regions of Turkey: The SEMT HT Study
Türkiye'nin Yedi Farklı Coğrafi Bölgesinde Hipertansiyon Sıklığı ve Farkındalığı: TEMD HT Çalışması
Received Date : 18 Aug 2020
Accepted Date : 27 Nov 2020
Available Online : 19 Jan 2021
Doi: 10.25179/tjem.2020-78532 - Makale Dili: EN
Turk J Endocrinol Metab. 2021;25:1-10
Bu makale, CC BY-NC-SA altında lisanslanmış açık erişim bir makaledir.
ABSTRACT
Objective: This study aimed to assess the prevalence, the level of awareness, and the factors that increase hypertension in Turkey. Material and Methods: A cross-sectional survey with a multi-stage probability sampling was conducted. A total of 9604 people were screened; of them, 9316 had a complete clinical examination. The ages, genders, personal and family histories of hypertension, diabetes, coronary artery diseases were recorded. Their systolic and diastolic blood pressures (BP), heights, weights, waist, and hip circumferences were measured. Hypertension was defined as taking medication for hypertension or BP ≥140/90 mmHg. Results: According to the JNC-7 criteria, 22.1% of the population had prehypertension, 36.5% had hypertension (15.3% stage 1 and 21.2% stage 2 hypertension), and 41.4% were normal population. Of the population, 30% had an awareness of hypertension. The prevalence of hypertension was higher in Mediterranean, Central Anatolia, and Black Sea Regions and lower in South-East Anatolia, Aegean Regions, while it was similar in Marmara and East Anatolia Regions when compared to the general population of Turkey. Though rural life, advancing age, increasing body mass index, and waist to height ratio >0.5 were the factors responsible for an increased prevalence of hypertension, smoking was found to decrease the prevalence. Conclusion: The data of the SEMT hypertension study indicated that more than onethird of the adult population was hypertensive in Turkey. Furthermore, only one-third of the hypertensive adult population showed awareness of their hypertension.
ÖZET
Amaç: Çalışmanın amacı, Türkiye'de hipertansiyon prevalansını, farkındalık düzeyini ve hipertansiyon prevalansını arttıran faktörleri değerlendirmekti. Gereç ve Yöntemler: Çok aşamalı olasılık örneklemesi ile kesitsel bir anket çalışması yapıldı. Toplam 9604 kişi tarandı, 9316’sının tam klinik muayenesi yapıldı. Yaş, cinsiyet, kişisel ve ailesel hipertansiyon, diyabet ve koroner arter hastalığı öyküleri kaydedildi. Sistolik ve diyastolik kan basınçları (KB), boy, vücut ağırlığı, bel ve kalça çevresi ölçümleri yapıldı. Hipertansiyon tanısı, hipertansiyon için bir ilaç almak veya KB ≥140/90 mmHg olarak tanımlandı. Bulgular: JNC-7’ye göre popülasyonun %22,1’inde prehipertansiyon, %36,5’inde hipertansiyon (%15,3’ünde evre 1 ve %21,2’sinde evre 2) ve %41,4’ünde normal tansiyon vardı. Hipertansiyon farkındalığı %30 idi. Hipertansiyon prevalansı Akdeniz, İç Anadolu ve Karadeniz Bölgelerinde daha yüksek, Güneydoğu Anadolu, Ege Bölgeleri'nde daha düşük, Marmara ve Doğu Anadolu Bölgeleri'nde ise Türkiye genel nüfusu ile benzer oranda bulundu. Kırsal yaşam, artan yaş, artan beden kitle indeksi ve bel/boy oranı >0,5 olması hipertansiyon prevalansını arttıran faktörler iken, sigara kullanımının düşük prevalans ile ilişkili olduğu bulundu. Sonuç: TEMD hipertansiyon çalışması verileri, Türkiye'de yetişkin nüfusun 1/3’ünden fazlasının hipertansif olduğunu göstermiştir. Dahası hipertansif yetişkin popülasyonun sadece 1/3’ünün hipertansiyonlarının farkında olmasıdır.
KAYNAKLAR
  1. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am. 1997;81:1077-1097.[Crossref] [PubMed] 
  2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;14;360:1903-1913. Erratum in: Lancet. 2003;22;361:1060.[Crossref] [PubMed] 
  3. World Health Organization. The world health report 2002. Reducing risks, promoting healthy life. Geneva: The Organization; 2002.[Link] 
  4. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;14;289:2363-2369.[PubMed] 
  5. Nissinen A, Bothig S, Granroth H, Lopez AD. Hypertension in developing countries. World Health Stat Q. 1988;41:141-153.[Link] 
  6. Accessed as 4 February 2020.[Link] 
  7. WHO Expert Committee. Physical status: the use and interpretation of anthropometry. WHO Technical Report Series No: 854. Geneva: WHO; 1995.[Link] 
  8. Sonmez A, Bayram F, Barcin C, Ozsan M, Kaya A, Gedik V. Waist circumference cutoff points to predict obesity, metabolic syndrome, and cardiovascular risk in Turkish adults. Int J Endocrinol. 2013;2013:767202.[Crossref] [PubMed] [PMC] 
  9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;21;289:2560-2572. Erratum in: JAMA. 2003;9;290:197.[PubMed] 
  10. Onat A, Dursunoglu D, Kahraman G, Ökçün B, Dönmez K, Keleş İ, Sansoy V. Türk erişkinlerinde kan basıncında yeni eğilimler: TEKHARF çalışması 1990 ve 1995 verilerinin analizi. Türk Kardiyol Dern Ars.1996;24:73-81.[Link] 
  11. Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, Sindel S, Erbay B, Hasanoğlu E, Cağlar S; Turkish Society of Hypertension and Renal Diseases. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005;23:1817-1823.[Crossref] [PubMed] 
  12. Arici M, Turgan C, Altun B, Sindel S, Erbay B, Derici U, Karatan O, Erdem Y, Hasanoglu E, Caglar S; Turkish Society of Hypertension and Renal Diseases. Hypertension incidence in Turkey (HinT): a population-based study. J Hypertens. 2010;28:240-244.[Crossref] [PubMed] 
  13. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28:169-180.[Crossref] [PubMed] [PMC] 
  14. Calbet JA. Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol. 2003;15;551:379-386.[Crossref] [PubMed] [PMC] 
  15. Fletcher EC. Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol (1985). 2001;90:1600-1605.[Crossref] [PubMed] 
  16. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;1;409:622-626.[Crossref] [PubMed] 
  17. Mingji C, Onakpoya IJ, Perera R, Ward AM, Heneghan CJ. Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review. Heart. 2015;101:1054-1060.[Crossref] [PubMed] [PMC] 
  18. Fiori G, Facchini F, Pettener D, Rimondi A, Battistini N, Bedogni G. Relationships between blood pressure, anthropometric characteristics and blood lipids in high- and low-altitude populations from Central Asia. Ann Hum Biol. 2000;27:19-28.[Crossref] [PubMed] 
  19. Widiarsih A, Susanna D, Eryando T. Consumption of salted fish containing high level of natrium chloride (NaCl) with hypertension incidence among people in area of salted fish industry. International Journal of Tropical Medicine. 2017;12:6-14.[Link] 
  20. Xu L, Wang S, Wang YX, Wang YS, Jonas JB. Prevalence of arterial hypertension in the adult population in rural and urban China: the Beijing eye study. Am J Hypertens. 2008;21:1117-1123.[Crossref] [PubMed] 
  21. Prabhakaran D, Chaturvedi V, Shah P, Manhapra A, Jeemon P, Shah B, Reddy KS. Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization. Chronic Illn. 2007;3:8-19.[Crossref] [PubMed] 
  22. Perez-Fernandez R, Mari-o AF, Cadarso-Suarez C, Botana MA, Tome MA, Solache I, Rego-Iraeta A, Mato AJ. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens. 2007;21:366-373.[Crossref] [PubMed] 
  23. King DE, Crisp JR. Rural-urban differences in factors associated with poor blood pressure control among outpatients. South Med J. 2006;99:1221-1223.[Crossref] [PubMed] 
  24. Grotto I, Huerta M, Sharabi Y. Hypertension and socioeconomic status. Curr Opin Cardiol. 2008;23:335-339.[Crossref] [PubMed] 
  25. Wolf HK, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A, Sans S, Dobson A, Keil U, Rywik S. Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens. 1997;11:733-742.[Crossref] [PubMed] 
  26. Ortega FB, Sui X, Lavie CJ, Blair SN. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality? Mayo Clin Proc. 2016;91:443-455.[Crossref] [PubMed] [PMC] 
  27. Mbanya VN, Kengne AP, Mbanya JC, Akhtar H. Body mass index, waist circumference, hip circumference, waist-hip-ratio and waist-height-ratio: which is the better discriminator of prevalent screen-detected diabetes in a Cameroonian population? Diabetes Res Clin Pract. 2015;108:23-30.[Crossref] [PubMed] 
  28. Park SH, Choi SJ, Lee KS, Park HY. Waist circumference and waist-to-height ratio as predictors of cardiovascular disease risk in Korean adults. Circ J. 2009;73:1643-1650.[Crossref] [PubMed] 
  29. Bennasar-Veny M, Lopez-Gonzalez AA, Tauler P, Cespedes ML, Vicente-Herrero T, Ya-ez A, Tomas-Salva M, Aguilo A. Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others. PLoS One. 2013;29;8:e63999.[Crossref] [PubMed] [PMC] 
  30. Ashwell M, Gibson S. Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet And Nutrition Survey of adults aged 19-64 years. Obes Facts. 2009;2:97-103.[Crossref] [PubMed] [PMC] 
  31. Gibson S. Ashwell M. Non-overweight 'apples' have higher cardiometabolic risk factors than overweight 'pears': waist-to-height ratio is a better screening tool than BMI for blood levels of total cholesterol and glycated haemoglobin. Obes Facts. 2015;8:139.[Link] 
  32. Sayeed MA, Mahtab H, Latif ZA, Khanam PA, Ahsan KA, Banu A, Azad Khan AK. Waist-to-height ratio is a better obesity index than body mass index and waist-to-hip ratio for predicting diabetes, hypertension and lipidemia. Bangladesh Med Res Counc Bull. 2003;29:1-10.[PubMed] 
  33. Cox BD, Whichelow MJ, Prevost AT. The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord. 1998;22:966-973.[Crossref] [PubMed] 
  34. Morillo MG, Amato MC, Cendon Filha SP. [Twenty-four hour blood pressure record for smokers and nonsmokers]. Arq Bras Cardiol. 2006;87:504-511.[Crossref] [PubMed] 
  35. St George IM, Williams S, Stanton WR, Silva PA. Smoking and blood pressure in 15 year olds in Dunedin, New Zealand. BMJ. 1991;2;302:89-90.[Crossref] [PubMed] [PMC] 
  36. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986;111:932-940.[Crossref] [PubMed] 
  37. Karvonen M, Orma E, Keys A, Fidanza F, Brozek J. Cigarette smoking, serum-cholesterol, blood-pressure, and body fatness; observations in Finland. Lancet. 1959;7;1:492-494.[Crossref] [PubMed] 
  38. Mikkelsen KL, Wiinberg N, Høegholm A, Christensen HR, Bang LE, Nielsen PE, Svendsen TL, Kampmann JP, Madsen NH, Bentzon MW. Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens. 1997;10:483-491.[PubMed] 
  39. Rehill N, Beck CR, Yeo KR, Yeo WW. The effect of chronic tobacco smoking on arterial stiffness. Br J Clin Pharmacol. 2006;61:767-773.[Crossref] [PubMed] [PMC] 
  40. Kristal-Boneh E, Harari G, Green MS. Seasonal change in 24-hour blood pressure and heart rate is greater among smokers than nonsmokers. Hypertension. 1997;30:436-441.[Crossref] [PubMed] 
  41. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Battistelli M, Gattobigio R, Sacchi N, Porcellati C. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens. 1995;13:1209-1215.[Crossref] [PubMed] 
  42. Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens. 1998;11:1153-1163.[Crossref] [PubMed] 
  43. Narkiewicz K, Maraglino G, Biasion T, Rossi G, Sanzioni F, Palatini P; The HARVEST Study Group (Italy). Interactive effect of cigarettes and coffee on daytime blood pressure in patients with mild essential hypertension. J Hypertension. 1995;13:965-970.[Crossref] [PubMed] 
  44. Bang LE, Buttenschøn L, Kristensen KS, Svendsen TL. Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives. Blood Press Monit. 2000;5:271-274.[Crossref] [PubMed]